Abstract
We describe the effect of a tricyclic antidepressant drug desipramine on voltage-dependent K+ (Kv) currents in freshly isolated rabbit coronary arterial smooth muscle cells using a conventional whole-cell patch clamp technique. Application of desipramine rapidly decreased the Kv current amplitude in a concentration-dependent manner, with an IC50 value of 5.91 ± 0.18 μM and a Hill coefficient of 0.61 ± 0.09. The steady-state inactivation curves of the Kv channels were not affected by desipramine. However, desipramine shifted the steady-state inactivation curves toward a more negative potential. Application of train pulses (1 or 2 Hz) slightly reduced the Kv current amplitude. Such reduction in the Kv current amplitude by train pulses increased in the presence of desipramine. Furthermore, the inactivation recovery time constant was also increased in the presence of desipramine, suggesting that desipramine-induced inhibition of the Kv current was use-dependent. Application of a Kv1.5 inhibitor (DPO-1) and/or a Kv2.1 inhibitor (guangxitoxin) did not change the inhibitory effect of desipramine on Kv currents. Based on these results, we concluded that desipramine directly inhibited the Kv channels in a dose- and state-dependent manner, but the effect was independent of norepinephrine/serotonin reuptake inhibition.
Similar content being viewed by others
References
DeVane, C. L. (1998). Differential pharmacology of newer antidepressants. Journal of Clinical Psychiatry, 59, 85–93.
Von Wolff, A., Hölzel, L. P., Westphal, A., Härter, M., & Kriston, L. (2013). Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis. Journal of Affective Disorders, 144, 7–15.
Luo, L., Xie, Y., Wang, A., Liu, X., Xiao, F., Zhong, X., et al. (2014). Desipramine ameliorates Cr(VI)-induced hepatocellular apoptosis via the inhibition of ceramide channel formation and mitochondrial PTP opening. Cellular Physiology and Biochemistry, 34, 2128–2136.
Brielmaier, J., Senerth, J. M., Silverman, J. L., Matteson, P. G., Millonig, J. H., DiCicco-Bloom, E., et al. (2014). Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. Genes, Brain and Behavior, 13, 286–298.
Mokhber, N., Abdollahian, E., Soltanifar, A., Samadi, R., Saghebi, A., Haghighi, M. B., et al. (2014). Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients. Pharmacopsychiatry, 47, 131–140.
Rudorfer, M. V., & Young, R. C. (1980). Anticholinergic effects and plasma desipramine levels. Clinical Pharmacology and Therapeutics, 28, 703–705.
White, N. C., Litovitz, T., & Clancy, C. (2008). Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology, 4, 238–250.
Zahradnik, I., Minarovic, I., & Zahradniková, A. (2008). Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics, 324, 977–984.
Staudacher, I., Wang, L., Wan, X., Obers, S., Wenzel, W., Tristram, F., et al. (2011). hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine. Naunyn-Schmiedeberg’s Archives of Pharmacology, 383, 119–139.
Dick, G. M., Bratz, I. Z., Borbouse, L., Payne, G. A., Dincer, U. D., Knudson, J. D., et al. (2008). Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation. American Journal of Physiology Heart and Circulatory Physiology, 294, 2371–2381.
Li, H., Hong, D. H., Kim, H. S., Kim, H. W., Jung, W. K., Na, S. H., et al. (2015). The calmodulin inhibitor CGS 9343B inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Toxicology and Applied Pharmacology, 15, 207–213.
Nelson, M. T., & Quayle, J. M. (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. American Journal of Physiology, 268, 799–822.
Ko, E. A., Han, J., Jung, I. D., & Park, W. S. (2008). Physiological roles of K+ channels in vascular smooth muscle cells. Journal of Smooth Muscle Research, 44, 65–81.
Shimoda, L. A., Sylvester, J. T., & Sham, J. S. (1998). Inhibition of voltage-dependent K+ currents in rat intrapulmonary arterial myocytes by endothelin-1. American Journal of Physiology, 274, 842–853.
Bae, Y. M., Kim, A., Kim, J., Park, W. S., Kim, T. K., Lee, Y. R., et al. (2006). Serotonin depolarizes the membrane potential in rat mesenteric artery myocytes by decreasing voltage-gated K+ currents. Biochemical and Biophysical Research Communications, 347, 468–476.
Doyon, G., & Bruemmer, D. (2016). Vascular smooth muscle cell dysfunction in diabetes: Nuclear receptors channel to relaxation. Clinical Science, 130, 1837–1839.
Liu, Y., & Gutterman, D. D. (2002). The coronary circulation in diabetes: Influence of reactive oxygen species on K+ channel-mediated vasodilation. Vascular Pharmacology, 38, 43–49.
Archer, S. L., London, B., Hampl, V., Wu, X., Nsair, A., Puttagunta, L., et al. (2001). Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. The FASEB Journal, 15, 1801–1803.
Cox, R. H., Folander, K., & Swanson, R. (2001). Differential expression of voltage-gated K+ channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension, 37, 1315–1322.
Gillman, P. K. (2007). Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology, 151, 737–748.
Lin, Z. Y., Chen, L. M., Zhang, J., Pan, X. D., Zhu, Y. G., Ye, Q. Y., et al. (2012). Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons. Acta Pharmacologica Sinica, 33, 438–444.
Wu, S. N., Hsu, M. C., Liao, Y. K., Wu, F. T., Jong, Y. J., & Lo, Y. C. (2012). Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K+ currents in motor neuron-like cells. Evidence-Based Complementary and Alternative Medicine, 2012, 148–403.
Kim, J. M., Park, W. S., Lin, H. Y., Shin, K. C., Sung, D. J., Kim, J. G., et al. (2015). Blockade of voltage-gated K+ currents in rat mesenteric arterial smooth muscle cells by MK801. Journal of Pharmacological Sciences, 127, 92–102.
Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Jung, W. K., Ha, K. S., et al. (2017). The selective serotonin reuptake inhibitor dapoxetine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Clinical and Experimental Pharmacology and Physiology, 44, 480–487.
Carignani, C., & Corsi, M. (2002). Inhibition of SK3 channels in the TE671 human medulloblastoma cell line by desipramine and imipramine. European Journal of Pharmacology, 448, 139–142.
Shin, S. E., Li, H., Kim, H. S., Kim, H. W., Seo, M. S., Ha, K. S., et al. (2017). Nortriptyline, a tricyclic antidepressant, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. The Korean Journal of Physiology & Pharmacology, 21, 225–232.
Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Choi, I. W., Firth, A. L., et al. (2016). Selective serotonin reuptake inhibitor sertraline inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Journal of Biosciences, 41, 659–666.
Hong, D. H., Li, H., Kim, H. S., Kim, H. W., Shin, S. E., Jung, W. K., et al. (2015). The effects of the selective serotonin reuptake inhibitor fluvoxamine on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Biological and Pharmaceutical Bulletin, 38, 1208–1213.
Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Seo, M. S., An, J. R., et al. (2017). Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. The Korean Journal of Physiology & Pharmacology, 21, 415–421.
Xu, C., Lu, Y., Tang, G., & Wang, R. (1999). Expression of voltage-dependent K+ channel genes in mesenteric artery smooth cells. American Journal of Physiology, 277, 1055–1063.
Yuan, X. J., Wang, J., Juhaszova, M., Golovina, V. A., & Rubin, L. J. (1998). Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. American Journal of Physiology, 274, 621–635.
Nichols, A. I., Abell, M., Chen, Y., Behrle, J. A., Frick, G., Paul, J., et al. (2013). Effect of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults. International Clinical Psychopharmacology, 28, 99–105.
Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea government (Ministry of Education: 2016-R1D1A3B03930169) (Ministry of Science, ICT and Future Planning: 2015-R1A4A1038666).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shin, S.E., Li, H., An, J.R. et al. Inhibition of the Voltage-Dependent K+ Current by the Tricyclic Antidepressant Desipramine in Rabbit Coronary Arterial Smooth Muscle Cells. Cardiovasc Toxicol 18, 252–260 (2018). https://doi.org/10.1007/s12012-017-9435-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-017-9435-x